Role of cetuximab in first-line treatment of metastatic colorectal cancer

The treatment of metastatic colorectal cancer (mCRC) has evolved considerably in the last decade, currently allowing most mCRC patients to live more than two years. Monoclonal antibodies targeting the epidermal growth factor receptor (EGFR) and vascular endothelial growth factor play an important ro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Sotelo, Miguel Jhonatan, García-Paredes, Beatriz, Aguado, Carlos, Sastre, Javier, Díaz-Rubio, Eduardo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Co., Limited 2014
Konular:
Topic Highlight
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3989957/
https://ncbi.nlm.nih.gov/pubmed/24764659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i15.4208
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller